ParkinsonCanadaV1, PascalFrancis, Curation, bibRecord, 000019

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations

Identifieur interne : 000019 ( PascalFrancis/Curation ); précédent : 000018; suivant : 000020

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations

Auteurs : I. Mendez [Canada] ; A. Dagher ; M. Hong ; A. Hebb ; P. Gaudet ; A. Law ; S. Weerasinghe ; D. King ; J. Desrosiers ; S. Darvesh ; T. Acorn ; H. Robertson

Source :

Journal of neurosurgery [ 0022-3085 ] ; 2000.

RBID : Pascal:00-0252924

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Facteur GDNF, Neurone dopaminergique, Greffe, Mésencéphale, Antérieur, Etude cas, Traitement, Survie, Technique, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Anterior, Case study, Dopaminergic neuron, Glial cell line derived neurotrophic factor, Graft, Human, Midbrain, Parkinson disease, Survival, Technique, Treatment.

Abstract

The authors have studied the ability of glial cell line-derived neurotrophic factor (GDNF) to promote survival of human fetal dopaminergic tissue after a storage period of 6 days and subsequent implantation into the human putamen. The results indicate that GDNF promotes survival of stored dopaminergic cells. Cells stored without GDNF had a 30.1% decrease in survival time compared with those exposed to GDNF. Two patients with Parkinson's disease received bilateral putaminal implants of fetal dopaminergic cells exposed to GDNF for 6 days and showed enhancement of graft survival as assessed by positron emission tomography scanning. A mean increase of 107% in putaminal fluoro-dopa uptake from baseline values was observed 12 months postgrafting.

A01	`01`	`1`		`@0 0022-3085`
A02	`01`			`@0 JONSAC`
A03		`1`		`@0 J. neurosurg.`
A05				`@2 92`
A06				`@2 5`
A08	`01`	`1`	`ENG`	`@1 Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations`
A11	`01`	`1`		`@1 MENDEZ (I.)`
A11	`02`	`1`		`@1 DAGHER (A.)`
A11	`03`	`1`		`@1 HONG (M.)`
A11	`04`	`1`		`@1 HEBB (A.)`
A11	`05`	`1`		`@1 GAUDET (P.)`
A11	`06`	`1`		`@1 LAW (A.)`
A11	`07`	`1`		`@1 WEERASINGHE (S.)`
A11	`08`	`1`		`@1 KING (D.)`
A11	`09`	`1`		`@1 DESROSIERS (J.)`
A11	`10`	`1`		`@1 DARVESH (S.)`
A11	`11`	`1`		`@1 ACORN (T.)`
A11	`12`	`1`		`@1 ROBERTSON (H.)`
A14	`01`			`@1 Departments of Surgery (Neurosurgery), Medicine (Neurology), Anaesthesia, and Gynaecology, Dalhousie University and Queen Elizabeth II Health Sciences Centre; Neural Transplantation Laboratory, Department of Anatomy and Neurobiology, and Departments @2 Halifax, Nova Scotia @3 CAN`
A14	`02`			`@1 McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University @2 Montreal, Quebec @3 CAN`
A20				`@1 863-869`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 6023 @5 354000082361930170`
A44				`@0 0000 @1 © 2000 INIST-CNRS. All rights reserved.`
A45				`@0 41 ref.`
A47	`01`	`1`		`@0 00-0252924`
A60				`@1 P @3 EC`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of neurosurgery`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 The authors have studied the ability of glial cell line-derived neurotrophic factor (GDNF) to promote survival of human fetal dopaminergic tissue after a storage period of 6 days and subsequent implantation into the human putamen. The results indicate that GDNF promotes survival of stored dopaminergic cells. Cells stored without GDNF had a 30.1% decrease in survival time compared with those exposed to GDNF. Two patients with Parkinson's disease received bilateral putaminal implants of fetal dopaminergic cells exposed to GDNF for 6 days and showed enhancement of graft survival as assessed by positron emission tomography scanning. A mean increase of 107% in putaminal fluoro-dopa uptake from baseline values was observed 12 months postgrafting.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Facteur GDNF @5 04`
C03	`02`	`X`	`ENG`	`@0 Glial cell line derived neurotrophic factor @5 04`
C03	`02`	`X`	`SPA`	`@0 Factor GDNF @5 04`
C03	`03`	`X`	`FRE`	`@0 Neurone dopaminergique @5 07`
C03	`03`	`X`	`ENG`	`@0 Dopaminergic neuron @5 07`
C03	`03`	`X`	`SPA`	`@0 Neurona dopaminérgica @5 07`
C03	`04`	`X`	`FRE`	`@0 Greffe @5 10`
C03	`04`	`X`	`ENG`	`@0 Graft @5 10`
C03	`04`	`X`	`SPA`	`@0 Injerto @5 10`
C03	`05`	`X`	`FRE`	`@0 Mésencéphale @5 13`
C03	`05`	`X`	`ENG`	`@0 Midbrain @5 13`
C03	`05`	`X`	`SPA`	`@0 Mesencéfalo @5 13`
C03	`06`	`X`	`FRE`	`@0 Antérieur @5 14`
C03	`06`	`X`	`ENG`	`@0 Anterior @5 14`
C03	`06`	`X`	`SPA`	`@0 Anterior @5 14`
C03	`07`	`X`	`FRE`	`@0 Etude cas @5 16`
C03	`07`	`X`	`ENG`	`@0 Case study @5 16`
C03	`07`	`X`	`SPA`	`@0 Estudio caso @5 16`
C03	`08`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`08`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`08`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`09`	`X`	`FRE`	`@0 Survie @5 18`
C03	`09`	`X`	`ENG`	`@0 Survival @5 18`
C03	`09`	`X`	`SPA`	`@0 Sobrevivencia @5 18`
C03	`10`	`X`	`FRE`	`@0 Technique @5 19`
C03	`10`	`X`	`ENG`	`@0 Technique @5 19`
C03	`10`	`X`	`SPA`	`@0 Técnica @5 19`
C03	`11`	`X`	`FRE`	`@0 Homme @5 20`
C03	`11`	`X`	`ENG`	`@0 Human @5 20`
C03	`11`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`06`	`X`	`FRE`	`@0 Chirurgie @5 61`
C07	`06`	`X`	`ENG`	`@0 Surgery @5 61`
C07	`06`	`X`	`SPA`	`@0 Cirugía @5 61`
N21				`@1 171`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D05

Links to Exploration step

Pascal:00-0252924

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations</title>
<author><name sortKey="Mendez, I" sort="Mendez, I" uniqKey="Mendez I" first="I." last="Mendez">I. Mendez</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Surgery (Neurosurgery), Medicine (Neurology), Anaesthesia, and Gynaecology, Dalhousie University and Queen Elizabeth II Health Sciences Centre; Neural Transplantation Laboratory, Department of Anatomy and Neurobiology, and Departments</s1>
<s2>Halifax, Nova Scotia</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University</s1>
<s2>Montreal, Quebec</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dagher, A" sort="Dagher, A" uniqKey="Dagher A" first="A." last="Dagher">A. Dagher</name>
</author>
<author><name sortKey="Hong, M" sort="Hong, M" uniqKey="Hong M" first="M." last="Hong">M. Hong</name>
</author>
<author><name sortKey="Hebb, A" sort="Hebb, A" uniqKey="Hebb A" first="A." last="Hebb">A. Hebb</name>
</author>
<author><name sortKey="Gaudet, P" sort="Gaudet, P" uniqKey="Gaudet P" first="P." last="Gaudet">P. Gaudet</name>
</author>
<author><name sortKey="Law, A" sort="Law, A" uniqKey="Law A" first="A." last="Law">A. Law</name>
</author>
<author><name sortKey="Weerasinghe, S" sort="Weerasinghe, S" uniqKey="Weerasinghe S" first="S." last="Weerasinghe">S. Weerasinghe</name>
</author>
<author><name sortKey="King, D" sort="King, D" uniqKey="King D" first="D." last="King">D. King</name>
</author>
<author><name sortKey="Desrosiers, J" sort="Desrosiers, J" uniqKey="Desrosiers J" first="J." last="Desrosiers">J. Desrosiers</name>
</author>
<author><name sortKey="Darvesh, S" sort="Darvesh, S" uniqKey="Darvesh S" first="S." last="Darvesh">S. Darvesh</name>
</author>
<author><name sortKey="Acorn, T" sort="Acorn, T" uniqKey="Acorn T" first="T." last="Acorn">T. Acorn</name>
</author>
<author><name sortKey="Robertson, H" sort="Robertson, H" uniqKey="Robertson H" first="H." last="Robertson">H. Robertson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0252924</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0252924 INIST</idno>
<idno type="RBID">Pascal:00-0252924</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D05</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000019</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations</title>
<author><name sortKey="Mendez, I" sort="Mendez, I" uniqKey="Mendez I" first="I." last="Mendez">I. Mendez</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Departments of Surgery (Neurosurgery), Medicine (Neurology), Anaesthesia, and Gynaecology, Dalhousie University and Queen Elizabeth II Health Sciences Centre; Neural Transplantation Laboratory, Department of Anatomy and Neurobiology, and Departments</s1>
<s2>Halifax, Nova Scotia</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University</s1>
<s2>Montreal, Quebec</s2>
<s3>CAN</s3>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Dagher, A" sort="Dagher, A" uniqKey="Dagher A" first="A." last="Dagher">A. Dagher</name>
</author>
<author><name sortKey="Hong, M" sort="Hong, M" uniqKey="Hong M" first="M." last="Hong">M. Hong</name>
</author>
<author><name sortKey="Hebb, A" sort="Hebb, A" uniqKey="Hebb A" first="A." last="Hebb">A. Hebb</name>
</author>
<author><name sortKey="Gaudet, P" sort="Gaudet, P" uniqKey="Gaudet P" first="P." last="Gaudet">P. Gaudet</name>
</author>
<author><name sortKey="Law, A" sort="Law, A" uniqKey="Law A" first="A." last="Law">A. Law</name>
</author>
<author><name sortKey="Weerasinghe, S" sort="Weerasinghe, S" uniqKey="Weerasinghe S" first="S." last="Weerasinghe">S. Weerasinghe</name>
</author>
<author><name sortKey="King, D" sort="King, D" uniqKey="King D" first="D." last="King">D. King</name>
</author>
<author><name sortKey="Desrosiers, J" sort="Desrosiers, J" uniqKey="Desrosiers J" first="J." last="Desrosiers">J. Desrosiers</name>
</author>
<author><name sortKey="Darvesh, S" sort="Darvesh, S" uniqKey="Darvesh S" first="S." last="Darvesh">S. Darvesh</name>
</author>
<author><name sortKey="Acorn, T" sort="Acorn, T" uniqKey="Acorn T" first="T." last="Acorn">T. Acorn</name>
</author>
<author><name sortKey="Robertson, H" sort="Robertson, H" uniqKey="Robertson H" first="H." last="Robertson">H. Robertson</name>
</author>
</analytic>
<series><title level="j" type="main">Journal of neurosurgery</title>
<title level="j" type="abbreviated">J. neurosurg.</title>
<idno type="ISSN">0022-3085</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of neurosurgery</title>
<title level="j" type="abbreviated">J. neurosurg.</title>
<idno type="ISSN">0022-3085</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anterior</term>
<term>Case study</term>
<term>Dopaminergic neuron</term>
<term>Glial cell line derived neurotrophic factor</term>
<term>Graft</term>
<term>Human</term>
<term>Midbrain</term>
<term>Parkinson disease</term>
<term>Survival</term>
<term>Technique</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Facteur GDNF</term>
<term>Neurone dopaminergique</term>
<term>Greffe</term>
<term>Mésencéphale</term>
<term>Antérieur</term>
<term>Etude cas</term>
<term>Traitement</term>
<term>Survie</term>
<term>Technique</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The authors have studied the ability of glial cell line-derived neurotrophic factor (GDNF) to promote survival of human fetal dopaminergic tissue after a storage period of 6 days and subsequent implantation into the human putamen. The results indicate that GDNF promotes survival of stored dopaminergic cells. Cells stored without GDNF had a 30.1% decrease in survival time compared with those exposed to GDNF. Two patients with Parkinson's disease received bilateral putaminal implants of fetal dopaminergic cells exposed to GDNF for 6 days and showed enhancement of graft survival as assessed by positron emission tomography scanning. A mean increase of 107% in putaminal fluoro-dopa uptake from baseline values was observed 12 months postgrafting.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-3085</s0>
</fA01>
<fA02 i1="01"><s0>JONSAC</s0>
</fA02>
<fA03 i2="1"><s0>J. neurosurg.</s0>
</fA03>
<fA05><s2>92</s2>
</fA05>
<fA06><s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MENDEZ (I.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DAGHER (A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HONG (M.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HEBB (A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GAUDET (P.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>LAW (A.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>WEERASINGHE (S.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>KING (D.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DESROSIERS (J.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>DARVESH (S.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>ACORN (T.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>ROBERTSON (H.)</s1>
</fA11>
<fA14 i1="01"><s1>Departments of Surgery (Neurosurgery), Medicine (Neurology), Anaesthesia, and Gynaecology, Dalhousie University and Queen Elizabeth II Health Sciences Centre; Neural Transplantation Laboratory, Department of Anatomy and Neurobiology, and Departments</s1>
<s2>Halifax, Nova Scotia</s2>
<s3>CAN</s3>
</fA14>
<fA14 i1="02"><s1>McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University</s1>
<s2>Montreal, Quebec</s2>
<s3>CAN</s3>
</fA14>
<fA20><s1>863-869</s1>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>6023</s2>
<s5>354000082361930170</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>41 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0252924</s0>
</fA47>
<fA60><s1>P</s1>
<s3>EC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of neurosurgery</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The authors have studied the ability of glial cell line-derived neurotrophic factor (GDNF) to promote survival of human fetal dopaminergic tissue after a storage period of 6 days and subsequent implantation into the human putamen. The results indicate that GDNF promotes survival of stored dopaminergic cells. Cells stored without GDNF had a 30.1% decrease in survival time compared with those exposed to GDNF. Two patients with Parkinson's disease received bilateral putaminal implants of fetal dopaminergic cells exposed to GDNF for 6 days and showed enhancement of graft survival as assessed by positron emission tomography scanning. A mean increase of 107% in putaminal fluoro-dopa uptake from baseline values was observed 12 months postgrafting.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Facteur GDNF</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Glial cell line derived neurotrophic factor</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Factor GDNF</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Neurone dopaminergique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Dopaminergic neuron</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Neurona dopaminérgica</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Greffe</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Graft</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Injerto</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Mésencéphale</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Midbrain</s0>
<s5>13</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Mesencéfalo</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Antérieur</s0>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Anterior</s0>
<s5>14</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Anterior</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Case study</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Survie</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Survival</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Sobrevivencia</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Technique</s0>
<s5>19</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Technique</s0>
<s5>19</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Técnica</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Chirurgie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Surgery</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Cirugía</s0>
<s5>61</s5>
</fC07>
<fN21><s1>171</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000019 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000019 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:00-0252924
   |texte=   Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations

Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease : Report of two cases and technical considerations

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri